Xin Jiang
Principal investigator, leads PROTEGO BIOPHARMA, INC..
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$2.4MFederal grants as PI2 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $2.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 1, 2021 | NIH | SBIR Phase II Analytical Validation of Non-native Transthyretin (NNTTR) As A Candidate Biomarker for Transthyretin Amyloidoses (ATTR) | $2.1M | PROTEGO BIOPHARMA, INC. |
| Mar 1, 2018 | NIH | SBIR Phase I Development of an early diagnostic and biomarker of treatment response for TTR amyloidoses (ATTR) | $325K | PROTEGO BIOPHARMA, INC. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#903
Awards as PI#1,503
Patents#505
Companies
- PROTEGO BIOPHARMA, INC.Leads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.